Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOT.

Saved in:

Bibliographic Details
Title:	Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOT.
Authors:	Dormegny-Jeanjean LC; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France.; CNRS UMR 7357 iCube, neurophysiology, FMTS, University of Strasbourg, Strasbourg, France., de Billy C; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France.; CNRS UMR 7357 iCube, neurophysiology, FMTS, University of Strasbourg, Strasbourg, France., Mainberger O; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France.; CNRS UMR 7357 iCube, neurophysiology, FMTS, University of Strasbourg, Strasbourg, France., Weibel S; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.; INSERM UMR 1114, Physiopathology and Cognitive Psychopathology of Schizophrenia, University of Strasbourg, Strasbourg, France., Schorr B; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.; INSERM UMR 1114, Physiopathology and Cognitive Psychopathology of Schizophrenia, University of Strasbourg, Strasbourg, France.; Geriatrics Department and Expert Center for Neurocognitive Disorders, University Hospital of Strasbourg, Strasbourg, France., Obrecht A; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France., Landré L; CNRS UMR 7357 iCube, neurophysiology, FMTS, University of Strasbourg, Strasbourg, France., Berna F; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.; INSERM UMR 1114, Physiopathology and Cognitive Psychopathology of Schizophrenia, University of Strasbourg, Strasbourg, France., Causin JB; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.; INSERM UMR 1114, Physiopathology and Cognitive Psychopathology of Schizophrenia, University of Strasbourg, Strasbourg, France., Blanc F; CNRS UMR 7357 iCube, neurophysiology, FMTS, University of Strasbourg, Strasbourg, France.; Geriatrics Department and Expert Center for Neurocognitive Disorders, University Hospital of Strasbourg, Strasbourg, France., Danila V; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Psychiatry 'Pole 8/9', Rouffach Psychiatric Hospital, Rouffach, France., Tomsa M; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Psychiatry 'Pole 8/9', Rouffach Psychiatric Hospital, Rouffach, France., Pfleger G; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Integrated Psychiatric Care, Centre Hospitalier d'Erstein, Erstein, France., Meyer C; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France.; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France., Humbert I; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France.; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France., Javelot H; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Expert center in Psychopharmacology, Etablissement public de santé Alsace nord (EPSAN), Bischwiller, France., Meyer G; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Psychopharmacology, Centre Hospitalier d'Erstein, Lingolsheim, France., Bertschy G; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.; INSERM UMR 1114, Physiopathology and Cognitive Psychopathology of Schizophrenia, University of Strasbourg, Strasbourg, France., Foucher JR; Treatment resistant depression expert center of Alsace (CEDRA), Strasbourg-Rouffach-Erstein-Brumath, Rouffach, France.; Non-Invasive neuroModulation Center of Strasbourg (CEMNIS), University Hospital of Strasbourg, Strasbourg, France.; CNRS UMR 7357 iCube, neurophysiology, FMTS, University of Strasbourg, Strasbourg, France.; Department of Psychiatry and Mental Health - University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.
Source:	Frontiers in psychiatry [Front Psychiatry] 2023 Sep 27; Vol. 14, pp. 1194090. Date of Electronic Publication: 2023 Sep 27 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-0640
DOI:	10.3389/fpsyt.2023.1194090